BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29466861)

  • 1. Flexibility-Not just for yoga anymore!
    Seley-Radtke K
    Antivir Chem Chemother; 2018; 26():2040206618756788. PubMed ID: 29466861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexibility as a Strategy in Nucleoside Antiviral Drug Design.
    Peters HL; Ku TC; Seley-Radtke KL
    Curr Med Chem; 2015; 22(34):3910-21. PubMed ID: 26282942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Reduction Sensitive Lipid Conjugates of Tenofovir: Antiviral Activity and Mechanism of Release.
    Giesler KE; Liotta DC
    J Med Chem; 2016 Nov; 59(22):10244-10252. PubMed ID: 27933889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosides.
    Du J; Surzhykov S; Lin JS; Newton MG; Cheng YC; Schinazi RF; Chu CK
    J Med Chem; 1997 Sep; 40(19):2991-3. PubMed ID: 9301659
    [No Abstract]   [Full Text] [Related]  

  • 5. L-Nucleosides as chemotherapeutic agents.
    Gumina G; Song GY; Chu CK
    FEMS Microbiol Lett; 2001 Aug; 202(1):9-15. PubMed ID: 11506901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New classes of fluorinated L-nucleosides; synthesis and antiviral activity.
    Lee K; Choi Y; Hong JH; Schinazi RF; Chu CK
    Nucleosides Nucleotides; 1999; 18(4-5):537-40. PubMed ID: 10432644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity.
    Giesler KE; Marengo J; Liotta DC
    J Med Chem; 2016 Aug; 59(15):7097-110. PubMed ID: 27405794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-nucleoside enantiomers as antivirals drugs: a mini-review.
    Mathé C; Gosselin G
    Antiviral Res; 2006 Sep; 71(2-3):276-81. PubMed ID: 16797735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.
    Cho JH; Bondana L; Detorio MA; Montero C; Bassit LC; Amblard F; Coats SJ; Schinazi RF
    Bioorg Med Chem; 2014 Dec; 22(23):6665-6671. PubMed ID: 25458500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flex-nucleoside analogues - Novel therapeutics against filoviruses.
    Yates MK; Raje MR; Chatterjee P; Spiropoulou CF; Bavari S; Flint M; Soloveva V; Seley-Radtke KL
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2800-2802. PubMed ID: 28465098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiviral nucleoside prodrugs await application.
    Anastasi C; Quéléver G; Burlet S; Garino C; Souard F; Kraus JL
    Curr Med Chem; 2003 Sep; 10(18):1825-43. PubMed ID: 12871107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance.
    Menéndez-Arias L; Álvarez M; Pacheco B
    Curr Opin Virol; 2014 Oct; 8():1-9. PubMed ID: 24814823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antiviral activities of [(dihydrofuran-2-yl)oxy]methyl-phosphonate nucleosides with 2-substituted adenine as base.
    Liu F; Liu Y; Xu RG; Dai G; Zhao LX; Wang Y; Liu HM; Liu FW; Pannecouque C; Herdewijn P
    Chem Biodivers; 2015 May; 12(5):813-22. PubMed ID: 26010668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E; Holý A
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
    Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
    Chen YL; Yokokawa F; Shi PY
    Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection.
    Wang Z; Kawaguchi K; Honda M; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):682-687. PubMed ID: 29752943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiviral activity of C-fluoro-branched cyclopropyl nucleosides.
    Kim A; Hong JH
    Eur J Med Chem; 2007 Apr; 42(4):487-93. PubMed ID: 17188402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of phosphonate nucleosides. 9-[(1-phosphonomethoxycyclopropyl)methyl]guanine as a potent and selective anti-HBV agent.
    Choi JR; Cho DG; Roh KY; Hwang JT; Ahn S; Jang HS; Cho WY; Kim KW; Cho YG; Kim J; Kim YZ
    J Med Chem; 2004 May; 47(11):2864-9. PubMed ID: 15139764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.